Health news round-up: vaccination, testosterone and neighbourhood health
The Pharmaceutical Journal provides a roundup of recent health developments, including new vaccination recommendations for meningococcal B and progress on Ebola and HIV vaccine trials. It also highlights concerns regarding the lack of national guidance on prescribing for hepatitis B reactivation.
Why it matters
These updates are critical for healthcare professionals and policymakers managing public health strategies and pharmaceutical regulations.
This week, The Pharmaceutical Journal has reported on developments around the single national formulary , a ‘stark lack of government response’ on valproate redress , the potential for a pharmacy performers list , and plans for closer regulatory ties between the UK, India and the United States.
We have also covered a National Institute for Health and Care Excellence (NICE) appraisal that recommends finerenone as an option for treating heart failure with preserved or mildly reduced ejection fraction; a study that suggests stopping antipsychotics in patients with dementia reduces their risk of fracture and delirium ; and a coroner’s concerns over a lack of national guidance on prescribing for hepatitis B reactivation .
Read on for more health news you might have missed this week.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in